Compositions and methods for the treatment of ophthalmic disease

Details for Australian Patent Application No. 2007293169 (hide)

Owner Allergan, Inc.

Inventors McLaughlin, Anne P.; Schweighoffer, Fabien J.; Mahe, Florence; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2007293169

PCT Pub. Number WO2008/029276

Priority 60/764,892 02.02.06 US

Filing date 2 February 2007

Wipo publication date 13 March 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2008/029276 Priority application(s): WO2008/029276

11 September 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read McLaughlin, Anne P.; Rodrigues, Gerard A.; Schweighoffer, Fabien J.; Mahe, Florence and Donello, John E. 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293171-Dock leveler with inflatable bag

2007293158-Method and device for preservation of packaged beverage preparing product